Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis
Author:
Funder
Merck
Iroko
Eli Lilly
Medtronic
Terumo
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference20 articles.
1. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention;Campo;Arch Intern Med,2011
2. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;King;J Am Coll Cardiol,2008
3. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents;Pfisterer;J Am Coll Cardiol,2006
4. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial;Valgimigli;Circulation,2012
5. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Editorial: Intravascular lithotripsy for post-implant stent under-expansion;Cardiovascular Revascularization Medicine;2023-11
2. Management of failed stenting of the unprotected left main coronary artery;Catheterization and Cardiovascular Interventions;2023-04
3. Predicting and Analyzing Restenosis Risk after Endovascular Treatment in Lower Extremity Arterial Disease: Development and Assessment of a Predictive Nomogram;Journal of Endovascular Therapy;2023-03-08
4. High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry;Clinical Research in Cardiology;2023-02-14
5. Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis;Medicine;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3